Dr. Lal Pathlabs Limited — Board/Management Information 2021

Jul 23, 2021

==> picture [289 x 39] intentionally omitted <==

July 23, 2021

National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Sandra Kurla Complex Sandra (E) Mumbai - 400 051

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001

Sub: Notice of Board Meeting

Ref: Regulation 29 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015

Dear Sir / Madam,

This is to inform you that a meeting of the Board of Directors is scheduled to be held on Friday, July 30, 2021, to inter-alia consider and approve the Unaudited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30, 2021 and to consider the proposal of declaration of interim dividend, if any, for the Financial Year 2021-22.

We request you to kindly take the same on record.

Thanking You,

Yours Faithfully,

For Dr. Lal PathLabs Limited Rajat Kalra Company Secretary and Legal Head

-.-9 I -I l-30258600, Fax: -.-91-11-2788-2134 122 001, Haryana +91-124-3016-500, Fax: +91- 124-4234-468

Regd. Office: Dr. Lal Pathlabs Ltd., Block E, Sector- I 8, Roh1rn, New Delhi - I !0085, Corporate Office: Dr. Lal PathLabs Ltd. I 2rh Floor. Tower B, SAS Tower, Medlc,ty, Sector-38, Gurugram -

E-mail: lalpathlabs@lalpathlabs com, Web: ww.-1.lalpathlabs.com, CIN No.: L74899DL I 99SPLC065388